High Court Ruling May Cost Home-Health Industry

High Court Ruling May Cost Home-Health Industry Play

June 15 (Bloomberg) -- The health-care industry stands to lose 11% of projected revenue over the next eight years if the U.S. Supreme Court strikes down the Affordable Care Act. Drug companies like Pfizer Inc., AstraZeneca Plc., and Novartis AG stand to gain billions in drug sales if the law is upheld. Bloomberg's Megan Hughes reports. (Source: Bloomberg)

blog comments powered by Disqus